MHRA Pharmacovigilance Context & Evidence Summary
The UK MHRA continuously monitors vaccine safety by comparing expected background rates of clinical conditions with passive reports in the Yellow Card scheme. Most post-vaccination events mirror background coincidence rates in infants.
Key Insight: Passive reporting triggers formal epidemiological cohort evaluations. A signal match near background levels confirms safety standards under robust surveillance.